Adglim Tablet 1 mg contains Glimepiride 1 mg, an oral antidiabetic medication used for the management of type 2 diabetes mellitus. It belongs to the sulfonylurea class of medicines, which help lower blood glucose levels by stimulating the pancreas to release insulin. Adglim is prescribed for patients whose blood sugar levels are not adequately controlled by diet, exercise, and lifestyle modifications alone.
Type 2 diabetes is characterized by insulin resistance and/or inadequate insulin secretion. Adglim helps improve glycemic control by increasing endogenous insulin production, thereby assisting in maintaining stable blood glucose levels throughout the day.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Glimepiride 1 mg
Glimepiride works by stimulating the beta cells of the pancreas to release insulin. It binds to specific sulfonylurea receptors on pancreatic cells, leading to insulin secretion in response to blood glucose levels.
As a result:
Blood glucose levels decrease.
Fasting and postprandial glucose levels improve.
HbA1c levels are reduced over time.
In addition to stimulating insulin release, Glimepiride may also improve peripheral insulin sensitivity to a certain extent, contributing to better overall glycemic control.
Adglim Tablet 1 mg is indicated for:
Management of Type 2 Diabetes Mellitus
Patients inadequately controlled by diet and exercise alone
Monotherapy or in combination with other oral antidiabetic agents such as metformin
Combination therapy with insulin when additional glycemic control is required
Effective Blood Sugar Reduction: Helps lower fasting and post-meal glucose levels.
Improves HbA1c: Supports long-term glycemic control.
Once-Daily Dosing: Convenient and easy to incorporate into daily routines.
Flexible Combination Therapy: Can be combined with other antidiabetic medications.
Cost-Effective Treatment Option: Widely used and well-established therapy.
The usual starting dose is 1 mg once daily, typically taken with breakfast or the first main meal of the day. The dosage may be adjusted by a healthcare professional based on individual blood glucose response and tolerance.
Patients should not skip meals while taking Glimepiride, as doing so may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential to ensure optimal dosing.
Risk of hypoglycemia, especially if meals are skipped, delayed, or if excessive physical activity occurs.
Use cautiously in elderly patients and those with renal or hepatic impairment.
Symptoms of low blood sugar may include sweating, dizziness, tremors, confusion, or palpitations.
Weight gain may occur in some patients.
Not recommended for patients with Type 1 diabetes or diabetic ketoacidosis.
Patients should inform their healthcare provider about all other medications and underlying medical conditions before starting Adglim Tablet 1 mg. Proper medical supervision and regular follow-up are essential for safe and effective diabetes management.
Login Or Registerto submit your questions to seller
No none asked to seller yet